Cancer Prevention and Screening

List of contributors vii
 
Foreword xi
 
Prologue xiii
 
1 Global perspectives surrounding cancer prevention and screening 1
Peter David Sasieni and Donald Maxwell Parkin
 
2 Public health perspectives surrounding cancer prevention and screening: The Ontario edition 19
Linda Rabeneck and Arlinda Ruco
 
3 Cancer screening: A general perspective 31
Otis W. Brawley
 
4 The balance of cancer screening risks and benefits 41
Julietta Patnick
 
5 Cancer screening issues in black and ethnic minority populations 51
Otis W. Brawley
 
6 Public awareness of cancer screening 57
Jane Wardle and Laura A.V. Marlow
 
7 Public understanding of cancer prevention 69
Jessica Kirby and Sarah Woolnough
 
8 Cervical cancer screening: An exemplar of a population screening programme and cervical cancer prevention 81
Albert Singer and Ashfaq Khan
 
9 Prevention of and screening for anal cancer 101
Andrew E. Grulich Richard J. Hillman and Isobel M. Poynten
 
10 The prevention of breast cancer 111
Anthony Howell Michelle N. Harvie Sacha J. Howell Louise S. Donnelly and D. Gareth Evans
 
11 Breast cancer: Population and targeted screening 129
Fiona J. Gilbert Fleur Kilburn-Toppin Valerie D.V. Sankatsing and Harry J de Koning
 
12 Prostate cancer prevention 145
Evan Kovac Andrew J. Stephenson Margaret G. House Eric A. Klein, and Howard L. Parnes
 
13 Population screening for prostate cancer 171
Richard J. Bryant Monique J. Roobol and Freddie C. Hamdy
 
14 Colon cancer prevention 183
John Burn and Harsh Sheth
 
15 Colon cancer screening 203
David F. Ransohoff
 
16 Lung cancer prevention 217
Jonathan M. Samet
 
17 Lung cancer screening 237
Christine D. Berg Kwun M. Fong and Henry M. Marshall
 
18 Mesothelioma: Screening in the modern age 257
Joanna Sesti Sabina Musovic Jessica S. Donington and Harvey I. Pass
 
19 Skin cancer prevention

ROSALIND A. EELES, MA (Cantab), PhD, FRCP, FRCR, FMedSCI is Professor of Oncogenetics and Team Leader in Oncogenetics at The Institute of Cancer Research and an Honorary Consultant in Cancer Genetics and Clinical Oncology at The Royal Marsden NHS Foundation Trust, London, UK
 
CHRISTINE D. BERG, MD is Special Advisor to the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Maryland, USA
 
JEFFREY S. TOBIAS, MA (Cantab), MD, FRCP, FRCR is Professor of Cancer Medicine at the Department of Oncology, University College London, and Honorary Consultant at University College Hospital Foundation Trust, London, U